Affinity Capital Advisors, LLC

SEC CIK: 0001810023
Latest filing: Jul 8, 2026

SEC filings (opens in a new tab)

EVLO holding history

Evelo Biosciences, Inc. in every 13F filed by Affinity Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EVLO overview All 13F holders of EVLO Full Q2 2026 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2023

Holdings of EVLO by Affinity Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−530−100.0%	Sold outConverted for a 1-for-20 split	Holders
Q1 2023	10,595	$1.92K	<0.1%	+10,595	New	Holders